Academic literature on the topic 'Incretin hormones'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Incretin hormones.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Incretin hormones"
Shah, Faraaz Ali, Hussain Mahmud, Teresa Gallego-Martin, Michael J. Jurczak, Christopher P. O’Donnell, and Bryan J. McVerry. "Therapeutic Effects of Endogenous Incretin Hormones and Exogenous Incretin-Based Medications in Sepsis." Journal of Clinical Endocrinology & Metabolism 104, no. 11 (June 19, 2019): 5274–84. http://dx.doi.org/10.1210/jc.2019-00296.
Full textGreen, Brian D., Clifford J. Bailey, and Peter R. Flatt. "Gliptin Therapies for Inhibiting Dipeptidyl Peptidase-4 in Type 2 Diabetes." European Endocrinology 6, no. 2 (2010): 19. http://dx.doi.org/10.17925/ee.2010.06.02.19.
Full textTsygankova, Oksana V., Varvara V. Veretyuk, and Alexander S. Ametov. "Incretins today: multiple effects and therapeutic potential." Diabetes mellitus 22, no. 1 (April 8, 2019): 70–78. http://dx.doi.org/10.14341/dm9841.
Full textMichałowska, Joanna, Ewa Miller-Kasprzak, and Paweł Bogdański. "Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical Perspective." Nutrients 13, no. 2 (January 25, 2021): 351. http://dx.doi.org/10.3390/nu13020351.
Full textDeacon, CF, S. Wamberg, P. Bie, TE Hughes, and JJ Holst. "Preservation of active incretin hormones by inhibition of dipeptidyl peptidase IV suppresses meal-induced incretin secretion in dogs." Journal of Endocrinology 172, no. 2 (February 1, 2002): 355–62. http://dx.doi.org/10.1677/joe.0.1720355.
Full textØrskov, Jens Juul Holst, Cathrine. "Incretin hormones - an update." Scandinavian Journal of Clinical and Laboratory Investigation 61, no. 234 (January 2001): 75–85. http://dx.doi.org/10.1080/clb.61.234.75.85.
Full textHolst, Jens Juul, and Cathrine Ørskov. "Incretin hormones - an update." Scandinavian Journal of Clinical and Laboratory Investigation 61, no. 7 (November 10, 2001): 75–85. http://dx.doi.org/10.1080/713783697.
Full textPhillips, Liza K., and Johannes B. Prins. "Update on incretin hormones." Annals of the New York Academy of Sciences 1243, no. 1 (December 2011): E55—E74. http://dx.doi.org/10.1111/j.1749-6632.2012.06491.x.
Full textEfendic, S., and N. Portwood. "Overview of Incretin Hormones." Hormone and Metabolic Research 36, no. 11/12 (November 2004): 742–46. http://dx.doi.org/10.1055/s-2004-826157.
Full textHolst, Jens Juul, and Cathrine Ørskov. "Incretin hormones – an update." Scandinavian Journal of Clinical and Laboratory Investigation 61, no. 7 (November 10, 2001): 75–85. http://dx.doi.org/10.1080/003655101317095455.
Full textDissertations / Theses on the topic "Incretin hormones"
Baggio, Laurie L. "The role of incretin hormones in glucose homeostasis." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 2001. http://www.collectionscanada.ca/obj/s4/f2/dsk3/ftp04/NQ59004.pdf.
Full textEdholm, Therese. "The role of incretin peptides and ghrelin in upper gut motility and metabolic control /." Stockholm, 2006. http://diss.kib.ki.se/2006/91-7140-937-8/.
Full textMoss, Catherine Elizabeth. "G-protein coupled receptors modulating incretin hormone secretion." Thesis, University of Cambridge, 2014. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.648611.
Full textMcCool, Katherine E. "The effect of diet and adiposity on the secretion of incretin hormones in cats." The Ohio State University, 2016. http://rave.ohiolink.edu/etdc/view?acc_num=osu1471605344.
Full textJoo, Erina. "The effects of nutrition intake on intestinal mucosal repair and metabolic regulation through gut hormones." Kyoto University, 2014. http://hdl.handle.net/2433/188804.
Full text0048
新制・課程博士
博士(人間・環境学)
甲第18366号
人博第679号
新制||人||163(附属図書館)
25||人博||679(吉田南総合図書館)
31224
京都大学大学院人間・環境学研究科共生人間学専攻
(主査)教授 林 達也, 教授 森谷 敏夫, 教授 石原 昭彦, 教授 津田 謹輔
学位規則第4条第1項該当
Parker, Helen Elizabeth. "Mechanisms underlying nutrient stimulated incretin hormone secretion." Thesis, University of Cambridge, 2010. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.608858.
Full textHabib, A. M. "Properties of incretin hormone secreting cells : a primary cells study." Thesis, University of Cambridge, 2010. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.599820.
Full textFernandes, Gustavo. "Avaliação do metabolismo glicêmico e perfil entero-hormonal no pós-operatório precose em pacientes abesos graves diabéticos submetidos à gastroplastia em Y de Roux.Comparação da oferta alimentar por via oral e por gastrostomia." Universidade de São Paulo, 2017. http://www.teses.usp.br/teses/disponiveis/5/5168/tde-29112017-091214/.
Full textINTRODUCTION: Type 2 diabetes mellitus (DM2) is a disease correlated with morbidly obesity. The obese patient has a suppressed incretin effect and consequent inbalance of glycemic homeostasis. Several studies have shown an improvement in DM2 after Gastroplasty with Roux-en-Y gastric bypass (RYGB). The mechanisms of glycemic control may be long-term and shortterm. The mechanisms of early action are linked to caloric restriction, improvement of insulin resistance, pancreatic beta cell function and return of the incretin effect through the increase of GLP1 and GIP, but the data are conflicting. METHODS: Eleven diabetic obese patients underwent RYGB with gastrostomy in gastric remnant after initial 10% weight loss. Patients were submitted to assessment of enterohormones, glycemic profile and Oral Glucose Tolerance Test (OGTT) in the preoperative period in a time curve that was compared to the postoperative period by Oral Via and Gastrostomy Via up to 7 days after the procedure .RESULTS: The mean age of the group was 46.09 ± 7.08 years. In the preoperative the mean weight was 120.97 ± 17.02 kilograms, height of 1.67 ± 0.11 meters, mean BMI of 44.06 ± 6, 59 kg/m2, mean fasting blood glucose of 194.55 ± 62.45 mg/dl and glycated hemoglobin 8.74 ± 1.64%. In 77.7% of the patients there was remission of DM2 in postoperative evaluated by the OGTT. Significant decrease in glycemia, insulinemia and HOMA-IR was also observed, regardless of the route of administration. There was a significant increase in GLP1 and reduction of GIP by the postoperative oral route. Ghrelin did not change. CONCLUSION: A reduction in glycemia and peripheral insulinal resistance was observed in early postoperative days of RYGB, independent of the food route. The change in incretin effect (increase of GLP1 and reduction of GIP) was only observed in the postoperative oral route
Abdullahi, Mohamed Mohamed. "GLP-1 REGULATES PROLIFERATION OF GLP-1 SECRETING CELLS THROUGH A FEEDBACK MECHANISM." Thesis, Mälardalen University, School of Sustainable Development of Society and Technology, 2010. http://urn.kb.se/resolve?urn=urn:nbn:se:mdh:diva-9756.
Full textAbstract Background and aim: Material and methods: Results/conclusions: These results suggest that GLP-1 regulates proliferation of the GLP-1-secreting cell through a feedback mechanism via its receptor. Since serum GLP-1 levels are decreased in type 2 diabetic patients, the effect of GLP-1 on the GLP-1-secreting cell proliferation suggested here provides a novel beneficial long-term effect of the incretin-based drugs in clinical practice i.e. through increase of the GLP-1-secreting cell mass, augmenting the incretin effect. In addition, the feedback mechanism action of GLP-1 reveals a new insight in regulation manner of the L-cell proliferation. Keywords:
Lu, Wendell J. "Role of Macronutrients in the Regulation and Secretory Mechanisms of Gastrointestinal Hormones, Glucagon-like Peptide-1 (GLP-1) and Glucose-dependent Insulinotropic Polypeptide (GIP), in Lymph." University of Cincinnati / OhioLINK, 2008. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1204084153.
Full textBooks on the topic "Incretin hormones"
Liu, Hui-Kang. Modification of the function of insulin-secreting cells by beta-cell toxins, differentiation drugs, insulin mimetics, steriods, and incretin hormones and their stable analogues. [S.l: The Author], 2003.
Find full textBaggio, Laurie L. The role of incretin hormones in glucose homeostasis. 2001.
Find full textHansotia, Tanya. Elucidating novel biological actions of the incretin hormones GLP-1 and GIP. 2006.
Find full textBook chapters on the topic "Incretin hormones"
Holst, Jens Juul. "Incretin hormones as a target for therapy." In Handbook of Incretin-based Therapies in Type 2 Diabetes, 11–30. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-08982-9_2.
Full textDe León, Diva D. "Role of Incretin Hormones in Hyperinsulinemic Hypoglycemia." In Monogenic Hyperinsulinemic Hypoglycemia Disorders, 79–86. Basel: KARGER, 2012. http://dx.doi.org/10.1159/000334509.
Full textThorens, Bernard. "The GIuco-Incretin Hormone Glucagon-Like Peptide-1 and Its β-Cell Receptor." In Molecular Biology of Diabetes, 357–79. Totowa, NJ: Humana Press, 1994. http://dx.doi.org/10.1007/978-1-4612-0241-7_15.
Full textC, Shivaprasad. "Incretin Hormones: Effects Beyond Glycemic Control." In Incretin Based Therapies, 18. Jaypee Brothers Medical Publishers (P) Ltd., 2013. http://dx.doi.org/10.5005/jp/books/11892_3.
Full textMcIntosh, Christopher H. S., Scott Widenmaier, and Su-Jin Kim. "Pleiotropic Actions of the Incretin Hormones." In Incretins and Insulin Secretion, 21–79. Elsevier, 2010. http://dx.doi.org/10.1016/b978-0-12-381517-0.00002-3.
Full textZietek, Tamara, Nadine Waldschmitt, and Eva Rath. "Role of Incretin Hormones in Bowel Diseases." In Developmental Biology of Gastrointestinal Hormones, 49–73. S. Karger AG, 2017. http://dx.doi.org/10.1159/000475731.
Full textIrwin, David M. "Evolution of Genes for Incretin Hormones and their Receptors." In Incretins and Insulin Secretion, 1–20. Elsevier, 2010. http://dx.doi.org/10.1016/b978-0-12-381517-0.00001-1.
Full textHolscher, Christian. "Protective Roles of the Incretin Hormones Glucagon-Like Peptide-1 and Glucose-Dependent Insolinotropic Polypeptide Hormones in Neurodegeneration." In Alzheimer's Disease Pathogenesis-Core Concepts, Shifting Paradigms and Therapeutic Targets. InTech, 2011. http://dx.doi.org/10.5772/18372.
Full text"The Incretin Effect: Regulation of Insulin Secretion and Glucose Tolerance by GI Hormones." In Diabetes, 135–50. CRC Press, 2008. http://dx.doi.org/10.3109/9781420047363-10.
Full text"Incretin Hormone." In Encyclopedia of Signaling Molecules, 2585. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-67199-4_105325.
Full textConference papers on the topic "Incretin hormones"
HASSAN, Neeran F. "USING INCRETIN IN TREATMENT OF DIABETES MELLITUS DISEASE." In IV.International Scientific Congress of Pure,Appliedand Technological Sciences. Rimar Academy, 2022. http://dx.doi.org/10.47832/minarcongress4-29.
Full textKartono, Agus, Rojali Fadila, Heryanto Syafutra, Setyanto Tri Wahyudi, and Tony Sumaryada. "The Modified Oral Minimal Model to Know Incretin Hormone Effect in Type 2 Diabetes Mellitus." In The 7th Engineering International Conference (EIC), Engineering International Conference on Education, Concept and Application on Green Technology. SCITEPRESS - Science and Technology Publications, 2018. http://dx.doi.org/10.5220/0009009802800286.
Full textKartono, Agus, Rojali Fadila, Heryanto Syafutra, Setyanto Tri Wahyudi, and Tony Sumaryada. "The Modified Oral Minimal Model to Know Incretin Hormone Effect in Type 2 Diabetes Mellitus." In The 7th Engineering International Conference (EIC), Engineering International Conference on Education, Concept and Application on Green Technology. SCITEPRESS - Science and Technology Publications, 2018. http://dx.doi.org/10.5220/0009009802860292.
Full text